Target intelligence / Profile preview

RNA, U6 small nuclear 271, pseudogene (RNU6-271P)

Target
RNU6-271P
Molecular classification
Other (Pseudogene), Non-coding RNA pseudogene
01

Overview

RNU6-271P refers to a pseudogene of U6 small nuclear RNA (snRNA); pseudogenes are genomic loci that resemble functional genes but are generally non-functional due to mutations or lack of regulatory elements[2]. The canonical U6 small nuclear RNA (snRNA) is a highly conserved, non-coding RNA that is a crucial part of the spliceosome complex, responsible for the removal of introns from precursor mRNA in eukaryotic nuclei[1][3]. However, RNU6-271P is not a functional gene but rather a “dead” copy, or remnant, of an ancestral U6 snRNA gene[3]. It does not encode a protein, is not known to produce a functional RNA product, and has no established biological function or disease role. Pseudogenes like RNU6-271P are common in the genome and typically do not serve as therapeutic targets, biomarkers, or have known drug interactions[2][3]. In rare cases, some pseudogenes may be transcribed and play regulatory roles (e.g., acting as microRNA decoys)[2], but there is no evidence for RNU6-271P functionality. This entry likely reflects a gene annotation artifact or a misinterpretation as a drug target or receptor. Key clarifications: - RNU6-271P is a pseudogene, not an actual RNA, protein, receptor, enzyme, or clinically actionable target. - It is not involved in signal transduction, gene regulation, or any canonical biological pathway. - There is nothing to suggest it is a therapeutic or diagnostic target. - Calling this a receptor or molecular target is incorrect.

Other names
RNU6-271P

Beyond the preview

Go deeper on RNA, U6 small nuclear 271, pseudogene (RNU6-271P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 271, pseudogene (RNU6-271P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call